CClinicalTrials.gg
Sign In
WithdrawnNCT00914836Updated Jun 23, 2015

Comparison of 2 Doses of Corticosteroid Subacromial Injections for the Treatment of Painful Shoulder

An interventional study of Betamethasone Sodium Phosphate and 1 cc - Betamethasone Sodium Phosphate in Tendonitis and Bursitis, sponsored by HaEmek Medical Center, Israel. Withdrawn at 1 site in Israel. Open to participants aged 35 Years and older. Per ClinicalTrials.gov, last updated 2015-06-23.

Sponsored by HaEmek Medical Center, Israel · Not applicable, Interventional, and Treatment

Why this study was withdrawn
difficulties in the department
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
35 Years and older
Sex
All
01

Study summary

The use of corticosteroid subacromial injections have been found to be effective for the treatment of shoulder pain. Higher doses may be better than lower doses for subacromial corticosteroid injection for rotator cuff tendonitis. The investigators aim this study to compare 2 doses of corticosteroids.

02

Conditions studied

  • Tendonitis
  • Bursitis

Keywords

  • shoulder
  • subacromion
  • corticosteroid
  • bursitis
  • tendinitis
  • calcific tendonitis
  • subacromial bursitis
  • rotator cuff tendinitis
03

In context

Tendinopathy

413 studies on the registry are indexed under Tendinopathy; 64 are open to participants now.

Browse Tendinopathy studies →

Lead sponsor

HaEmek Medical Center, Israel is the lead sponsor of 228 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
35 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • subacromial bursitis
  • tendinitis
  • Calcific Tendonitis

Exclusion criteria

Exclusion Criteria:

  • rotator cuff tear
  • osteoarthritis
  • pregnancy
  • local or systemic infection
  • steroid or lidocaine sensitivity
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Active comparator
    1 cc - Betamethasone Sodium Phosphate

    1 cc - Betamethasone Sodium Phosphate

    Drug: Betamethasone Sodium Phosphate · Drug: 1 cc - Betamethasone Sodium Phosphate

  • Active comparator
    2 cc - Betamethasone Sodium Phosphate

    2 cc - Betamethasone Sodium Phosphate

    Drug: Betamethasone Sodium Phosphate · Drug: 2 cc - Betamethasone Sodium Phosphate

Interventions

  • DrugBetamethasone Sodium Phosphate

    1cc:2cc

    Also known as: diprospan

  • Drug1 cc - Betamethasone Sodium Phosphate

    Betamethasone Sodium Phosphate

    Also known as: diprospan

  • Drug2 cc - Betamethasone Sodium Phosphate

    Betamethasone Sodium Phosphate

    Also known as: diprospan

06

What researchers measure

Primary outcomes

  1. constant score

    Time frame: 9 month

07

Study locations

1 site
  • Haemek Medical Center
    Afula, Israel
08

References and documents

Publications

  • van der Heijden GJ, van der Windt DA, Kleijnen J, Koes BW, Bouter LM. Steroid injections for shoulder disorders: a systematic review of randomized clinical trials. Br J Gen Pract. 1996 May;46(406):309-16. PubMed 8762750 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 23, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00914836
Lead sponsor
HaEmek Medical Center, Israel
First posted
Jun 5, 2009
Start date
Jun 2009
Primary completion
Apr 2010
Completion
Apr 2010
Last update
Jun 23, 2015

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Jun 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Tendinopathy→

Other studies from this sponsor

HaEmek Medical Center, Israel

Start the discussion